SARS-COV-2 infection and outcomes in chronic dialysis patients

Background: The SARS-COV-2 pandemic (COVID) impacted ESRD patients on dialysis, categorized by the CDC as immunocompromised We describe the characteristics and outcomes in patients treated by a non-profit dialysis provider Methods: From 2/17 to 5/29, 2020, Dialysis Clinic Inc had identified 422 COVID+ patients from 90 clinics in 20 states We compared their characteristics relative to the uninfected source clinic population (N=6,993) and tracked outcomes over the 15-week period Results: Comparative characteristics are shown in the table (∗p<0 05) Hospitalization occurred in 295 (70%) with 75 deaths, 159 discharges and 61 still hospitalized Ten patients died <30 days post-discharge Another 11 deaths occurred in 116 non-hospitalized patients Overall, 96 of 422 died (22 7%) While more black patients were infected, death rates were higher in white than black dialysis patients (31 5% vs 18 8%, p=0 008) Conclusions: Chronic dialysis patients with COVID have higher death rates than the general population Infected patients tended to be older, with more comorbidity, particularly DM/CVD, and utilized respiratory inhalers/assistance Group home residents were overrepresented with COVID while home dialysis patients were disproportionately spared